These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15645203)

  • 21. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia.
    Hinsberger AD; Williamson PC; Carr TJ; Stanley JA; Drost DJ; Densmore M; MacFabe GC; Montemurro DG
    J Psychiatry Neurosci; 1997 Mar; 22(2):111-7. PubMed ID: 9074305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 31P-MR spectroscopy in children and adolescents with a familial risk of schizophrenia.
    Rzanny R; Klemm S; Reichenbach JR; Pfleiderer SO; Schmidt B; Volz HP; Blanz B; Kaiser WA
    Eur Radiol; 2003 Apr; 13(4):763-70. PubMed ID: 12664115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
    Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study.
    Keshavan MS; Stanley JA; Montrose DM; Minshew NJ; Pettegrew JW
    Mol Psychiatry; 2003 Mar; 8(3):316-23, 251. PubMed ID: 12660804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophrenia.
    Szulc A; Galińska-Skok B; Tarasów E; Konarzewska B; Waszkiewicz N; Hykiel R; Walecki J
    Med Sci Monit; 2012 Jun; 18(6):CR390-8. PubMed ID: 22648255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies.
    Shioiri T; Hamakawa H; Kato T; Fujii K; Murashita J; Inubushi T; Someya T
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(4):169-74. PubMed ID: 11009069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia.
    Kalaycı D; Ozdel O; Sözeri-Varma G; Kıroğlu Y; Tümkaya S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):176-81. PubMed ID: 22306485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectral analysis of multichannel MRS data.
    Sandgren N; Stoica P; Frigo FJ; Selén Y
    J Magn Reson; 2005 Jul; 175(1):79-91. PubMed ID: 15949751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: a combined MRI and 1H-MRS study.
    Klär AA; Ballmaier M; Leopold K; Häke I; Schaefer M; Brühl R; Schubert F; Gallinat J
    Neuroimage; 2010 Oct; 53(1):51-7. PubMed ID: 20541020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
    Bustillo JR; Rowland LM; Jung R; Brooks WM; Qualls C; Hammond R; Hart B; Lauriello J
    Neuropsychopharmacology; 2008 Sep; 33(10):2456-66. PubMed ID: 18094668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy.
    Deicken RF; Zhou L; Schuff N; Fein G; Weiner MW
    Biol Psychiatry; 1998 Apr; 43(7):483-8. PubMed ID: 9547926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorus magnetic resonance spectroscopy studies in schizophrenia.
    Yuksel C; Tegin C; O'Connor L; Du F; Ahat E; Cohen BM; Ongur D
    J Psychiatr Res; 2015 Sep; 68():157-66. PubMed ID: 26228415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilson's disease: (31)P and (1)H MR spectroscopy and clinical correlation.
    Sinha S; Taly AB; Ravishankar S; Prashanth LK; Vasudev MK
    Neuroradiology; 2010 Nov; 52(11):977-85. PubMed ID: 20174787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in neuroimaging in schizophrenia: magnetic resonance spectroscopy].
    Galińska B; Szulc A; Walecki J; Kubas B; Tarasów E
    Pol Merkur Lekarski; 2003 Sep; 15(87):278-80. PubMed ID: 14679857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies.
    Schwerk A; Alves FD; Pouwels PJ; van Amelsvoort T
    J Neurochem; 2014 Jan; 128(1):1-87. PubMed ID: 23937509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.
    Soares JC; Krishnan KR; Keshavan MS
    Depression; 1996; 4(1):14-30. PubMed ID: 9160650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia.
    Szulc A; Konarzewska B; Galinska-Skok B; Lazarczyk J; Waszkiewicz N; Tarasow E; Milewski R; Walecki J
    Neurosci Lett; 2013 Jun; 547():37-41. PubMed ID: 23665527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls.
    Tang CY; Friedman J; Shungu D; Chang L; Ernst T; Stewart D; Hajianpour A; Carpenter D; Ng J; Mao X; Hof PR; Buchsbaum MS; Davis K; Gorman JM
    BMC Psychiatry; 2007 Jun; 7():25. PubMed ID: 17578565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.